Yi Chang
Director/Board Member at NONGFU SPRING CO., LTD.
Profile
Yi Chang is currently an Independent Non-Executive Director at Nongfu Spring Co., Ltd., YishengBio Co., Ltd., Sipai Health Technology Co., Ltd., and Cowealth Medical China Co., Ltd.
He is also a Member of the China Institute of Internal Audit and the Asian Development Bank China.
In addition, he is a Professor at Shanghai Advanced Institute of Finance and the Managing Partner at Grant Thornton LLP (China).
Previously, Dr. Chang served as an Independent Director at YS Biopharma Co. Ltd.
and Chief Operating Officer at Marcum Asia CPAs LLP.
He was also a Professor at National Taiwan University from 2016 to 2018 and a Partner at Ernst & Young (China) from 2007 to 2016.
Additionally, he was a Member of the Texas State Board of Public Accountancy.
Dr. Chang's education includes a graduate degree from the University of Missouri in 1983, a doctorate degree from Texas Tech University in 1987, and an undergraduate degree from National Taiwan University in 1980.
Yi Chang active positions
| Companies | Position | Start |
|---|---|---|
| NONGFU SPRING CO., LTD. | Director/Board Member | 2020-03-05 |
| SIPAI HEALTH TECHNOLOGY CO., LTD. | Director/Board Member | 2021-07-29 |
| COWEALTH MEDICAL CHINA CO.,LTD. | Director/Board Member | 2019-03-21 |
| China Institute of Internal Audit | Corporate Officer/Principal | - |
| Asian Development Bank China | Corporate Officer/Principal | - |
| Shanghai Advanced Institute of Finance | Corporate Officer/Principal | 2018-06-30 |
| Grant Thornton LLP (China) | Corporate Officer/Principal | - |
YishengBio Co., Ltd.
 YishengBio Co., Ltd. BiotechnologyHealth Technology Yishengbio Co., Ltd. is an investment holding company that engages in the research and development, manufacture, and sale of vaccines and therapeutic biologics for infectious diseases and cancer. It focuses on the PIKA immunomodulation technology platform and production, sale of YSJA rabies vaccine. Its geographical segment include Mainland China, and other countries. The company was founded by Yi Zhang on November 16, 2020 and is headquartered in China. | Director/Board Member | 2021-01-18 |
Former positions of Yi Chang
| Companies | Position | End |
|---|---|---|
| YS BIOPHARMA CO., LTD. | Director/Board Member | 2023-12-08 |
| ░░░░░░░░ ░░░░░░ ░░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░ ░░░░░ ░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░ ░░░░░ ░░ ░░░░░░ ░░░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
| ░░░░░░ ░░░░ ░░░░ ░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | - |
Training of Yi Chang
| University of Missouri | Graduate Degree |
| Texas Tech University | Doctorate Degree |
| National Taiwan University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 4 |
|---|---|
| NONGFU SPRING CO., LTD. | Consumer Non-Durables |
| SIPAI HEALTH TECHNOLOGY CO., LTD. | Retail Trade |
| COWEALTH MEDICAL CHINA CO.,LTD. | Health Technology |
| YS BIOPHARMA CO., LTD. | Health Technology |
| Private companies | 7 |
|---|---|
| Texas State Board of Public Accountancy | |
| China Institute of Internal Audit | |
| Ernst & Young (China) | |
Marcum Asia CPAs LLP
 Marcum Asia CPAs LLP Miscellaneous Commercial ServicesCommercial Services Part of Marcum Wealth LLC, Marcum Asia CPAs LLP provides public accounting services. The private company is based in Beijing, China. The CEO of the Chinese company is Enze Liang. | Commercial Services |
| Asian Development Bank China | Government |
| Grant Thornton LLP (China) | |
YishengBio Co., Ltd.
YishengBio Co., Ltd. BiotechnologyHealth Technology Yishengbio Co., Ltd. is an investment holding company that engages in the research and development, manufacture, and sale of vaccines and therapeutic biologics for infectious diseases and cancer. It focuses on the PIKA immunomodulation technology platform and production, sale of YSJA rabies vaccine. Its geographical segment include Mainland China, and other countries. The company was founded by Yi Zhang on November 16, 2020 and is headquartered in China. | Health Technology |
- Stock Market
- Insiders
- Yi Chang